Table 3: Treatment methods and BED
|
No. |
RT1 |
RT2 |
RT3 |
RT1-ELF |
RT2-LF |
RT3-LF |
TD |
BED-2 |
BED-3 |
BED-10 |
CTX/IMT |
|
|
/Enr |
/Enr |
/Enr |
Gy/fr |
Gy/fr |
Gy/fr |
Gy/fr |
Gy |
Gy |
Gy |
|
|
1 |
E/6 |
E/6 |
55/22 |
8/4 |
63/26 |
140 |
114 |
78 |
DX, PX, ETP |
||
|
2 |
El/6 |
El/6 |
62.5/25 |
5/2 |
67.5/27 |
152 |
124 |
84 |
DX, IL-2, PX |
||
|
3 |
E/12 |
E/9 |
62.5/25 |
7.5/3 |
70/28 |
158 |
128 |
88 |
ETP |
||
|
4 |
E/9 |
E/6 |
62.5/25 |
7.5/3 |
70/28 |
158 |
128 |
88 |
IL-2, DX |
||
|
5 |
E/6 |
E/6 |
65/26 |
7.5/3 |
72.5/29 |
163 |
133 |
91 |
PX, ETP |
||
|
6 |
E/9 |
E/6, 9 |
E/6 |
65/26 |
5/2 |
3.5/1 |
73.5/29 |
167 |
136 |
92 |
PX |
|
7 |
E/9 |
E/6, 9 |
E/6 |
45/18 |
15/6 |
12.5/5 |
72.5/29 |
163 |
133 |
91 |
DX |
|
8 |
E/9 |
E/9 |
E/6 |
65/26 |
7.5/3 |
2.5/1 |
75/30 |
169 |
138 |
94 |
IL-2 |
|
9 |
X/4 |
X/4 |
E/6 |
60/24 |
10/4 |
5/2 |
75/30 |
169 |
138 |
94 |
DX |
|
10 |
X/4 |
E/6 |
|
65/26 |
10/4 |
|
75/30 |
169 |
138 |
94 |
DX |
RT:
Radiotherapy, Enr: Energy (MeV or MV), ELF: Extended
Local Field, LF: Local Field, TD: Total Dose, fr: Fractions,
BED:
Biologically Effective Dose, CTX: Chemotherapy, IMT: Immunotherapy, E: Electron
Beam, X: X-ray,
DX:
Docetaxel, PX: Paclitaxel, ETP: Etoposide, IL-2: Recombinant Interleukin-2.
BED-2,
BED-3, and BED-10 were calculated by the LQ model using assumed alpha/beta
ratios of 2, 3, and 10,
respectively.